INSM brensocatib approved in Japan for bronchiectasis
INSM says brinsupri (brensocatib) has been approved by Japan’s Ministry of Health, Labour and Welfare for patients with non-cystic fibrosis bronchiectasis.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.